Lost in translation: modulation of the metabolic-functional relation in the diabetic human heart

Circulation. 2009 Apr 21;119(15):2020-2. doi: 10.1161/CIRCULATIONAHA.109.854323.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Animals
  • Diabetes Complications / drug therapy
  • Diabetes Complications / etiology
  • Diabetes Complications / physiopathology
  • Diabetes Mellitus, Experimental / drug therapy
  • Diabetes Mellitus, Experimental / physiopathology
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / metabolism*
  • Fatty Acids / metabolism*
  • Female
  • Heart / drug effects
  • Heart / physiopathology*
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use
  • Insulin Resistance / physiology
  • Male
  • Metabolic Syndrome / metabolism*
  • Metformin / pharmacology
  • Metformin / therapeutic use
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Oxidation-Reduction
  • PPAR alpha / physiology
  • Pioglitazone
  • Sulfonylurea Compounds / pharmacology
  • Sulfonylurea Compounds / therapeutic use
  • Thiazolidinediones / pharmacology
  • Thiazolidinediones / therapeutic use
  • Ventricular Dysfunction, Left / drug therapy
  • Ventricular Dysfunction, Left / etiology

Substances

  • Fatty Acids
  • Hypoglycemic Agents
  • PPAR alpha
  • Sulfonylurea Compounds
  • Thiazolidinediones
  • glimepiride
  • Metformin
  • Pioglitazone